Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fireman B.V. (NQ: IFRX )

1.900 +0.100 (+5.56%)
Streaming Delayed Price Updated: 11:57 AM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,042
Open 1.850
Bid (Size) 1.890 (5)
Ask (Size) 1.930 (3)
Prev. Close 1.800
Today's Range 1.850 - 1.950
52wk Range 0.7762 - 3.280
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
What 5 Analyst Ratings Have To Say About InflaRx
  InflaRx (NASDAQ:IFRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
InflaRx: Q2 Earnings Insights
  InflaRx (NASDAQ:IFRX) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings InflaRx reported EPS of $0.01. 
Via Benzinga

Performance

YTD
-36.67%
-36.67%
1 Month
-6.86%
-6.86%
3 Month
-38.31%
-38.31%
6 Month
-13.64%
-13.64%
1 Year
-18.80%
-18.80%

More News

Read More
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Via Benzinga
InflaRx Shares Are Flying Higher After Emergency Use Nod Plans For Its COVID-19 Treatment
Via Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Via Benzinga
Why Is InflaRx (IFRX) Stock Up 40% Today?
Via InvestorPlace
InflaRx Provides Development Update For Vilobelimab In Skin Disorder, COVID-19
Via Benzinga
Read Why Did Raymond James Slash Price Target On Inflarx
Via Benzinga
Crude Oil Drops 1%; General Motors Earnings Miss Views
Via Benzinga
Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings
Via Benzinga
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
Via Benzinga
InflaRx's Stock Gains Following FDA Fast Track Status To Skin Disease Drug
Via Benzinga
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Via Benzinga
LiveOne And 24 Stocks Moving Premarket
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Via Benzinga
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Via Benzinga
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Epizyme + 20 Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.